Catalyst Wire Dossier Catalyst Wire Dossier

Tavalisse

fostamatinib · Rigel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Tavalisse, covering 2012-12-28 to 2025-02-04. Get the full timeline:

Most recent: FDA Approved: TAVALISSE — Supplemental Application (Rigel Pharmaceuticals, Inc.)

See pricing